These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16688299)

  • 1. [Epidemiology of multiresistance in Gram-negative non-fermenting bacilli].
    Calvo J
    Rev Esp Quimioter; 2006 Mar; 19(1):86. PubMed ID: 16688299
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gram-negative bacilli isolated in a general hospital: high rate of ciprofloxacin resistance].
    García del Busto Remón A; Pardo F; Moreno R; Galiano JV
    Enferm Infecc Microbiol Clin; 1996 Apr; 14(4):276-7. PubMed ID: 9044652
    [No Abstract]   [Full Text] [Related]  

  • 3. A step closer to extreme drug resistance (XDR) in gram-negative bacilli.
    Paterson DL; Doi Y
    Clin Infect Dis; 2007 Nov; 45(9):1179-81. PubMed ID: 17918079
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-fermentative Gram-negative bacteria.
    Enoch DA; Birkett CI; Ludlam HA
    Int J Antimicrob Agents; 2007 May; 29 Suppl 3():S33-41. PubMed ID: 17659210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug-resistant Gram-negative bacteria in postoperative infections.
    Singh AV; Mishra B; Thakur A
    J Indian Med Assoc; 2009 Mar; 107(3):148-50, 163. PubMed ID: 19810380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology.
    Falagas ME; Karageorgopoulos DE
    Clin Infect Dis; 2008 Apr; 46(7):1121-2; author reply 1122. PubMed ID: 18444833
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of multiresistance of gram-negative bacteria in bloodstream infection on mortality rates and length of stay.
    Sostarich AM; Zolldann D; Haefner H; Luetticken R; Schulze-Roebecke R; Lemmen SW
    Infection; 2008 Feb; 36(1):31-5. PubMed ID: 18231721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tigecycline resistance in Australian antibiotic-resistant Gram-negative bacteria.
    Iredell J; Thomas L; Power D; Mendes E
    J Antimicrob Chemother; 2007 Apr; 59(4):816-8. PubMed ID: 17353224
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology of multi-drug resistant gramnegative bacilli].
    Ruiz-Garbajosa P; Cantón R
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():21-5. PubMed ID: 27608308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of multiresistant bacteria in German intensive care units.
    Meyer E; Gastmeier P; Schwab F
    J Antimicrob Chemother; 2008 Dec; 62(6):1474-6. PubMed ID: 18794158
    [No Abstract]   [Full Text] [Related]  

  • 11. High level resistance in gram negative bacilli.
    Gupta N; Aparna ; Saini S; Arora DR
    Indian J Pathol Microbiol; 2004 Oct; 47(4):594-5. PubMed ID: 16295409
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI; Anzueto A
    Semin Respir Crit Care Med; 2009 Feb; 30(1):61-6. PubMed ID: 19199188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of colistin against multidrug-resistant gram-negative bacteria isolated at a major army hospital during the military campaigns in Iraq and Afghanistan.
    Paolino K; Erwin D; Padharia V; Carrero H; Giron L; Burgess R; Burger C; Martinez M; Arrieta P; Wortmann G; Zapor M
    Clin Infect Dis; 2007 Jul; 45(1):140-1. PubMed ID: 17554723
    [No Abstract]   [Full Text] [Related]  

  • 15. Bacterial colonization: can we live with it?
    Kirkland KB
    Clin Infect Dis; 2009 May; 48(10):1382-4. PubMed ID: 19348595
    [No Abstract]   [Full Text] [Related]  

  • 16. The current state of multidrug-resistant gram-negative bacilli in North America.
    Nicasio AM; Kuti JL; Nicolau DP
    Pharmacotherapy; 2008 Feb; 28(2):235-49. PubMed ID: 18225969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The far-reaching impact of antimicrobial resistance.
    Rehm SJ; Weber JT
    Clin Infect Dis; 2007 Sep; 45 Suppl 2():S97-8. PubMed ID: 17683021
    [No Abstract]   [Full Text] [Related]  

  • 18. How can we stem the rising tide of multidrug-resistant gram-negative bacilli?
    Maragakis LL; Perl TM
    Infect Control Hosp Epidemiol; 2010 Apr; 31(4):338-40. PubMed ID: 20175689
    [No Abstract]   [Full Text] [Related]  

  • 19. Correct use of the term 'pan-drug-resistant' (PDR) Gram-negative bacteria.
    Falagas ME; Kasiakou SK
    Clin Microbiol Infect; 2005 Dec; 11(12):1049-50. PubMed ID: 16307565
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug resistant gram-negative bacteria in clinical isolates from Karachi.
    Saeed A; Khatoon H; Ansari FA
    Pak J Pharm Sci; 2009 Jan; 22(1):44-8. PubMed ID: 19168419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.